Floatz logo

Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pegargiminase
Prostate Cancer
M.D. Anderson Cancer CenterP1/2CC (46)
Personalized Neoantigen Peptide Vaccine
Cancer
Seqker Biosciences, Inc.P1/2CC (46)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318
Ependymoma
National Cancer Institute (NCI)P1/2CC (46)
Precemtabart Tocentecan
Neoplasm
EMD Serono Research & Development Institute, Inc.P1/2CC (46)
Prilocaine
Cognitive Disorder
University of Dublin, Trinity CollegeP1/2CC (46)
Recombinant Human Granulocyte Colony-Stimulating Factor
Acute Lymphoblastic Leukemia
City of Hope Medical CenterP1/2CC (46)
Recombinant Human Interferon Α1B
Melanoma
Xijing HospitalP1/2CC (46)
Relatlimab
Non-Hodgkin Lymphoma
Bristol-Myers SquibbP1/2CC (46)
Retifanlimab
Neoplasm
Incyte CorporationP1/2CC (46)
Ribociclib
Endometrial Carcinoma
Avenzo Therapeutics, Inc.P1/2CC (46)
Rimiducid
Aplastic Anemia
Bellicum PharmaceuticalsP1/2CC (46)
Rimiducid
Hemoglobinopathy
Bellicum PharmaceuticalsP1/2CC (46)
Rimiducid
Childhood Acute Myeloid Leukemia
Bellicum PharmaceuticalsP1/2CC (46)
Rimiducid
Osteopetrosis
Bellicum PharmaceuticalsP1/2CC (46)
Ris-Rez
Neoplasm
GlaxoSmithKlineP1/2CC (46)
Rmc-9805
Non-Small Cell Lung Carcinoma
Tango Therapeutics, Inc.P1/2CC (46)
Roginolisib
Non-Small Cell Lung Carcinoma
iOncturaP1/2CC (46)
Saruparib
Non-Small Cell Lung Carcinoma
University of LeedsP1/2CC (46)
Sirolimus
Parkinson Disease
Royan InstituteP1/2CC (46)
Surufatinib
Primary Peritoneal Carcinoma
Sun Yat-sen UniversityP1/2CC (46)
Surufatinib
Rhabdomyosarcoma
HutchmedP1/2CC (46)
T-Dxd
Gastric Cancer
Iambic Therapeutics, IncP1/2CC (46)
Temuterkib
Colorectal Cancer
The Netherlands Cancer InstituteP1/2CC (46)
TIL
Glioblastoma
Essen BiotechP1/2CC (46)
Tinengotinib
Biliary Tract Cancer
TransThera Sciences (Nanjing), Inc.P1/2CC (46)
Showing 2826 to 2850 of 6,305 assets
PreviousPage 114 of 253Next